-- Discontinuation to occur by August 1; CVS will offer more ephedra-free products to continue meeting the weight-loss needs of its customers --
WOONSOCKET, R.I., July 11 -- CVS/pharmacy announced today that as of August 1, 2003, it will discontinue the sale of all ephedra-based diet products at its 4,100 stores.
Beginning August 1, inventory of all remaining ephedra-based products will be removed from all CVS stores, and transactions for any ephedra-based product will be automatically blocked at the cash register.
"We believe that ephedra-based products are safe when used as directed," said Chris Bodine, Executive Vice President of Merchandising and Marketing at CVS/pharmacy. "However, with several communities where we have stores taking steps to ban products with ephedra, we have decided to discontinue the sale of these products."
"CVS is a leading retail healthcare destination for consumers, and we will continue serving the needs of our customers seeking weight-loss solutions by enhancing our offering of ephedra-free dietary products," said Bodine.
Celebrating 40 years of dynamic growth in the retail pharmacy industry, CVS is committed to being the easiest pharmacy retailer for customers to use. CVS has created innovative approaches to serve the healthcare needs of all of its customers through its over 4,100 CVS/pharmacy stores; its online pharmacy, CVS.com; and its pharmacy benefit management and specialty pharmacy subsidiary, PharmaCare Management Services. General information about CVS is available through the Investor Relations portion of the Company's website, at http://investor.cvs.com/.